New high-cost cell-based gene therapy drug Encelto approved for use in the ambulatory surgical center (ASC) setting
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center...
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center...
View this special edition update on processing of telehealth and acute hospital care at home claims.
To enhance efficiency and ensure the secure handling of appeal information, all providers will be required to use SPOT to check...
View this special edition on recent CMS actions.
IDTFs are required to report the exact CPT/HCPCS codes and procedures they intend to perform when enrolling with the CMS-855B...
This special edition includes information on lifting the current claims hold.
View this special edition regarding a claims hold update and an NCCI alert.
This is your opportunity to hear directly from the Medicare contractors regarding Medicare’s criteria necessary for the coverage...
Read this article, which provides billing guidance for acute kidney injury.
Reminder: The preliminary 2026 portable x-ray transportation payment rates have been posted for notice. The comment period is...